Analgesics in Singapore

Analgesics in Singapore

Demand for systemic analgesics continued to normalise in Singapore in 2024 following the surge in purchases seen in 2022. During the peak of the COVID-19 pandemic and its aftermath, consumers stockpiled these products to self-medicate for post-vaccination symptoms and common cold symptoms caused by later variants of the virus. With the threat of COVID-19 having largely been mitigated, the urgency to purchase systemic analgesics has decreased, leading to a stabilisation in the growth rate.

Euromonitor International's Analgesics in Singapore report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2020-2024, allowing you to identify the sectors driving growth. Forecasts to 2029 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.